I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Rothmann, Mark D
39
results:
Articles (Online) X
Search for persons
X
Languages
english (35)
german (4)
Sorted by: Relevance
Sorted by: Year
?
1
Finding the (biomarker-defined) subgroup of patients who be..:
McShane, Lisa Meier
;
Rothmann, Mark D
;
Fleming, Thomas R
Clinical Trials. 20 (2023) 4 - p. 341-350 , 2023
Link:
https://doi.org/10.1177/..
?
2
Perspectives on informative Bayesian methods in pediatrics:
Travis, James
;
Rothmann, Mark
;
Thomson, Andrew
Journal of Biopharmaceutical Statistics. 33 (2023) 6 - p. 830-843 , 2023
Link:
https://doi.org/10.1080/..
?
3
14th Annual University of Pennsylvania Conference on statis..:
Imai, Kosuke
;
Rosenblum, Michael
;
Rothmann, Mark
Clinical Trials. 20 (2023) 4 - p. 405-415 , 2023
Link:
https://doi.org/10.1177/..
?
4
Innovations in Pediatric Therapeutics Development: Principl..:
Fleming, Thomas R.
;
Garnett, Christine E.
;
Conklin, Laurie S.
...
Therapeutic Innovation & Regulatory Science. 57 (2022) 1 - p. 109-120 , 2022
Link:
https://doi.org/10.1007/..
?
5
Retrieved-Dropout-Based multiple imputation for time-to-eve..:
He, Jiwei
;
Crackel, Roberto
;
Koh, William
...
Journal of Biopharmaceutical Statistics. 33 (2022) 2 - p. 234-252 , 2022
Link:
https://doi.org/10.1080/..
?
6
Bayesian Methods in Human Drug and Biological Products Deve..:
Ionan, Alexei C.
;
Clark, Jennifer
;
Travis, James
...
Therapeutic Innovation & Regulatory Science. 57 (2022) 3 - p. 436-444 , 2022
Link:
https://doi.org/10.1007/..
?
7
Should responder analyses be conducted on continuous outcom..:
Abugov, Robert
;
Clark, Jennifer
;
Higginbotham, Laura
...
Pharmaceutical Statistics. 22 (2022) 2 - p. 312-327 , 2022
Link:
https://doi.org/10.1002/..
?
8
Statement on P-values:
Gwise, Thomas
;
Rothmann, Mark D.
;
James Hung, H.M.
...
Statistics in Biopharmaceutical Research. 13 (2021) 1 - p. 57-58 , 2021
Link:
https://doi.org/10.1080/..
?
9
Resampling‐based stepwise multiple testing procedures with ..:
He, Jiwei
;
Li, Feng
;
Gao, Yan
.
Pharmaceutical Statistics. 20 (2020) 2 - p. 297-313 , 2020
Link:
https://doi.org/10.1002/..
?
10
Assessing and communicating heterogeneity of treatment effe..:
Rothmann, Mark
;
Crown, William
;
Louis, Thomas A.
...
Pharmaceutical Statistics. 20 (2020) 5 - p. 952-964 , 2020
Link:
https://doi.org/10.1002/..
?
11
Statistical Considerations on Subgroup Analysis in Clinical..:
Alosh, Mohamed
;
Fritsch, Kathleen
;
Huque, Mohammad
...
Statistics in Biopharmaceutical Research. 7 (2015) 4 - p. 286-303 , 2015
Link:
https://doi.org/10.1080/..
?
12
U.S. Food and Drug Administration Approval Summary: Omaceta..:
Alvandi, Firoozeh
;
Kwitkowski, Virginia E.
;
Ko, Chia-Wen
...
The Oncologist. 19 (2013) 1 - p. 94-99 , 2013
Link:
https://doi.org/10.1634/..
?
13
Evaluating and Adjusting for Premature Censoring of Progres..:
Rothmann, Mark
;
Koti, Kallappa
;
Lee, Kyung Yul
...
Journal of Biopharmaceutical Statistics. 23 (2013) 5 - p. 1091-1105 , 2013
Link:
https://doi.org/10.1080/..
?
14
Testing in a Prespecified Subgroup and the Intent-to-Treat ..:
Rothmann, Mark D.
;
Zhang, Jenny J.
;
Lu, Laura
.
Drug Information Journal. 46 (2012) 2 - p. 175-179 , 2012
Link:
https://doi.org/10.1177/..
?
15
Some essential considerations in the design and conduct of ..:
Fleming, Thomas R
;
Odem-Davis, Katherine
;
Rothmann, Mark D
.
Clinical Trials. 8 (2011) 4 - p. 432-439 , 2011
Link:
https://doi.org/10.1177/..
1-15